Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 1
2009 1
2010 3
2011 4
2012 7
2013 9
2014 9
2015 7
2016 8
2017 9
2018 7
2019 11
2020 3
2021 3
2022 8
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Among authors: cambiano v. Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2. Lancet. 2019. PMID: 31056293 Free PMC article.
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Asboe D, Viciana P, Gutiérrez F, Clotet B, Pradier C, Gerstoft J, Weber R, Westling K, Wandeler G, Prins JM, Rieger A, Stoeckle M, Kümmerle T, Bini T, Ammassari A, Gilson R, Krznaric I, Ristola M, Zangerle R, Handberg P, Antela A, Allan S, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Among authors: cambiano v. JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148. JAMA. 2016. PMID: 27404185 Free article.
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa.
Phillips AN, Sibanda E, Sikwese K, Bansi-Matharu L, Cambiano V, Rodger A, Lundgren J, Shahmanesh M, Gilks C, Godfrey C, Ehrenkranz P, Hargreaves JR, Revill P, Cowan F. Phillips AN, et al. Among authors: cambiano v. AIDS. 2022 Aug 1;36(10):1473-1475. doi: 10.1097/QAD.0000000000003258. AIDS. 2022. PMID: 35876709 Free article. No abstract available.
'Test-and-treat': the end of the HIV epidemic?
Cambiano V, Rodger AJ, Phillips AN. Cambiano V, et al. Curr Opin Infect Dis. 2011 Feb;24(1):19-26. doi: 10.1097/QCO.0b013e3283422c8c. Curr Opin Infect Dis. 2011. PMID: 21157329 Review.
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis.
Phillips AN, Bansi-Matharu L, Shahmanesh M, Hargreaves JR, Smith J, Revill P, Sibanda E, Ehrenkranz P, Sikwese K, Rodger A, Lundgren JD, Gilks CF, Godfrey C, Cowan F, Cambiano V. Phillips AN, et al. Among authors: cambiano v. Lancet Glob Health. 2023 Oct;11(10):e1648-e1657. doi: 10.1016/S2214-109X(23)00383-2. Lancet Glob Health. 2023. PMID: 37734807 Free article.
94 results